BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1373201)

  • 1. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate.
    Pathak VK; Temin HM
    J Virol; 1992 May; 66(5):3093-100. PubMed ID: 1373201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in protein domains outside the catalytic site of the bacteriophage Qβ replicase reduce the mutagenic effect of 5-azacytidine.
    Cabanillas L; Sanjuán R; Lázaro E
    J Virol; 2014 Sep; 88(18):10480-7. PubMed ID: 24965463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
    Jeronimo PMC; Aksenen CF; Duarte IO; Lins RD; Miyajima F
    J Virol; 2024 Jan; 98(1):e0140423. PubMed ID: 38088350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-shaped distribution of the relative substitution rate (c/μ) observed for SARS-COV-2's genome, inconsistent with the selectionist theory, the neutral theory and the nearly neutral theory but a near-neutral balanced selection theory: Implication on "neutralist-selectionist" debate.
    Wu C; Paradis NJ; Lakernick PM; Hryb M
    Comput Biol Med; 2023 Feb; 153():106522. PubMed ID: 36638615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity.
    Hadj Hassine I; Ben M'hadheb M; Menéndez-Arias L
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylodynamic study of the conserved RNA structure encompassing the hemagglutinin cleavage site encoding region of H5 and H7 low pathogenic avian influenza viruses.
    Dupré G; Hoede C; Figueroa T; Bessière P; Bertagnoli S; Ducatez M; Gaspin C; Volmer R
    Virus Evol; 2021 Sep; 7(2):veab093. PubMed ID: 35299790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mfd regulates RNA polymerase association with hard-to-transcribe regions in vivo, especially those with structured RNAs.
    Ragheb MN; Merrikh C; Browning K; Merrikh H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
    Pereira F
    Infect Genet Evol; 2020 Nov; 85():104525. PubMed ID: 32890763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring Alphavirus Fidelity Using Non-Infectious Virus Particles.
    Patterson EI; Khanipov K; Swetnam DM; Walsdorf S; Kautz TF; Thangamani S; Fofanov Y; Forrester NL
    Viruses; 2020 May; 12(5):. PubMed ID: 32429270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.
    Graepel KW; Lu X; Case JB; Sexton NR; Smith EC; Denison MR
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses.
    Pauly MD; Procario MC; Lauring AS
    Elife; 2017 Jun; 6():. PubMed ID: 28598328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of viral mutation.
    Sanjuán R; Domingo-Calap P
    Cell Mol Life Sci; 2016 Dec; 73(23):4433-4448. PubMed ID: 27392606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The external domains of the HIV-1 envelope are a mutational cold spot.
    Geller R; Domingo-Calap P; Cuevas JM; Rossolillo P; Negroni M; Sanjuán R
    Nat Commun; 2015 Oct; 6():8571. PubMed ID: 26450412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anti-HIV-1 mutagenic nucleoside analogues.
    Vivet-Boudou V; Isel C; El Safadi Y; Smyth RP; Laumond G; Moog C; Paillart JC; Marquet R
    J Biol Chem; 2015 Jan; 290(1):371-83. PubMed ID: 25398876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on HIV-1 antiretroviral drug resistance.
    Iyidogan P; Anderson KS
    Viruses; 2014 Oct; 6(10):4095-139. PubMed ID: 25341668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant lethal mutagenesis of human immunodeficiency virus type 1.
    Dapp MJ; Holtz CM; Mansky LM
    J Mol Biol; 2012 Jun; 419(3-4):158-70. PubMed ID: 22426127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.
    Menéndez-Arias L
    Viruses; 2009 Dec; 1(3):1137-65. PubMed ID: 21994586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.
    Abram ME; Ferris AL; Shao W; Alvord WG; Hughes SH
    J Virol; 2010 Oct; 84(19):9864-78. PubMed ID: 20660205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.
    Dapp MJ; Clouser CL; Patterson S; Mansky LM
    J Virol; 2009 Nov; 83(22):11950-8. PubMed ID: 19726509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering Evolutionary Mechanisms Between Mutualistic and Pathogenic Symbioses.
    Nishiguchi MK; Hirsch AM; Devinney R; Vedantam G; Riley MA; Mansky LM
    Vie Milieu; 2008; 58(2):87-106. PubMed ID: 19655044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.